WC

Wharton Capital

North America, New York, United States, New York

Description

Wharton Capital Corporation Formed in 1978.

Investor Profile

Wharton Capital has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series C rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series C (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Wharton Capital frequently co-invest with?

GB
North America, Massachusetts, United States, Framingham
Co-Investments: 1
SD
North America, Utah, United States, Salt Lake City
Co-Investments: 1

What are some of recent deals done by Wharton Capital?

Merrimack

Cambridge, Massachusetts, United States

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

BiotechnologyHealth CarePharmaceutical
Series CMay 5, 2004
Amount Raised: $28,000,000